Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blinded, Placebo-controlled, Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® in Obese or Overweight Subjects With Elevated Blood Glucose Levels

NCT06087822 is registered in ClinicalTrials.gov with Sigrid Therapeutics AB as lead sponsor.

NCT NCT06087822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blinded, Placebo-controlled, Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® in Obese or Overweight Subjects With Elevated Blood Glucose Levels
Lead sponsor
Sigrid Therapeutics AB
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2023
Completion date
July 30, 2024
Enrollment
318 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

overweight or obesity